InBios International
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, InBios International sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
InBios International: 5 sponsored US clinical trials, none currently recruiting.
InBios International sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Infectious Diseases, with 2 trials.
Upper-quartile sponsor footprint
InBios International sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use
NCT06734741
Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)
NCT04320485
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
NCT03776903
Specificity Study of Diagnostic for Chagas Disease
NCT02544139
Specificity Study of Diagnostic for Early Detection of Dengue Infection
NCT02107677
Therapeutic Areas
How the InBios International archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Infectious Diseases (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
InBios International: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
InBios International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this InBios International page
5 registered trials is a research-attention snapshot, not an endorsement of InBios International or any single study.
- None of InBios International's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Infectious Diseases is the condition InBios International studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infectious Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
InBios International pipeline card: 5 registered trials from official public datasets.Report a data error.